Cited by 303Protein Tyrosine PhosphatasesGenomics and Rare DiseasesProtein Kinase Regulation and GTPase Signaling

Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum

Open access
Sarkozy, Anna, Carta, Claudio, Moretti, Sonia, Zampino, Giuseppe, Digilio, Maria C., Pantaleoni, Francesca, Scioletti, Anna Paola, Esposito, Giorgia +19 more·2009·Human Mutation

Abstract

Noonan, LEOPARD, and cardiofaciocutaneous syndromes (NS, LS, and CFCS) are developmental disorders with overlapping features including distinctive facial dysmorphia, reduced growth, cardiac defects, skeletal and ectodermal anomalies, and variable cognitive deficits. Dysregulated RAS-mitogen-activated protein kinase (MAPK) signal traffic has been established to represent the molecular pathogenic cause underlying these conditions. To investigate the phenotypic spectrum and molecular diversity of germline mutations affecting BRAF, which encodes a serine/threonine kinase functioning as a RAS effector frequently mutated in CFCS, subjects with a diagnosis of NS (N=270), LS (N=6), and CFCS (N=33), and no mutation in PTPN11, SOS1, KRAS, RAF1, MEK1, or MEK2, were screened for the entire coding sequence of the gene. Besides the expected high prevalence of mutations observed among CFCS patients (52%), a de novo heterozygous missense change was identified in one subject with LS (17%) and five individuals with NS (1.9%). Mutations mapped to multiple protein domains and largely did not overlap with cancer-associated defects. NS-causing mutations had not been documented in CFCS, suggesting that the phenotypes arising from germline BRAF defects might be allele specific. Selected mutant BRAF proteins promoted variable gain of function of the kinase, but appeared less activating compared to the recurrent cancer-associated p.Val600Glu mutant. Our findings provide evidence for a wide phenotypic diversity associated with mutations affecting BRAF, and occurrence of a clinical continuum associated with these molecular lesions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/humu.20955

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BRAF is implicated in Noonan, Leopard, and Cardiofaciocutaneous syndromes, with typical symptoms including prominent forehead, bitemporal narrowing, hypertelorism, short stature, and other skeletal, cardiac, and craniofacial anomalies, frequently accompanied by moderate to severe mental retardation.

    “BRAF is implicated in Noonan, Leopard, and Cardiofaciocutaneous syndromes, typical symptoms of which include prominent forehead, bitemporal narrowing, hypertelorism, and short stature, among other skeletal, cardiac, and craniofacial anomalies, frequently accompanied by moderate to severe mental retardation [72, 73].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Sarkozy A Digilio MC Zampino G Dallapiccola B Tartaglia M Gelb BD 2009 LEOPARD syndrome: clinical aspects and molecular pathogenesis Zenker M Monographs in Human Genetics - Vol. 17. Noonan syndrome and related disorders: A matter of deregulated RAS signaling Basel Karger Press 55 65
  2. Tartaglia M Gelb BD 2009 Molecular genetics of Noonan syndrome Zenker M Monographs in Human Genetics - Vol. 17. Noonan syndrome and related disorders: A matter of deregulated RAS signaling Basel Karger Press 20 39

Cited by

Sorted by citations

Authors
Sarkozy, A., Carta, C., Moretti, S., Zampino, G., Digilio, M. C., Pantaleoni, F., Scioletti, A. P., Esposito, G., Cordeddu, V., Lepri, F., Petrangeli, V., Dentici, M. L., Mancini, G. M. S., Selicorni, A., Rossi, C., Mazzanti, L., Marino, B., Ferrero, G. B., Silengo, M. C., Memo, L., Stanzial, F., Faravelli, F., Stuppia, L., Puxeddu, E., Gelb, B. D., Dallapiccola, B., & Tartaglia, M.
Affiliations
  • Istituto Superiore di Sanità (IT)
  • University of Perugia (IT)
  • Università Cattolica del Sacro Cuore (IT)
  • Bambino Gesù Children's Hospital (IT)
  • University of Chieti-Pescara (IT)
  • Casa Sollievo della Sofferenza (IT)
  • Istituti di Ricovero e Cura a Carattere Scientifico (IT)
  • Erasmus MC (NL)
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
  • Policlinico Umberto I (IT)
  • University of Turin (IT)
  • Ospedale Policlinico San Martino (IT)
  • Ospedale di Bolzano (IT)
  • Ente Ospedaliero Ospedali Galliera (IT)
  • Icahn School of Medicine at Mount Sinai (US)
Venue
Human Mutation
Publisher
Wiley
Published
2009-04
Volume
30
Issue
4
Pages
695-702
ISSN
  • 1059-7794 (ISSN-L)
  • 1098-1004
OpenAlex
W1972449266
Cited by
303
References
53
Citations by year
2026: 11 · 2025: 10 · 2024: 28 · 2023: 9 · 2022: 15 · 2021: 19 · 2020: 11 · 2019: 19 · 2018: 19 · 2017: 26 · 2016: 16 · 2015: 20 · 2014: 20 · 2013: 14 · 2012: 19
FWCI
8.87
Type
journal article
Language
en
Open access
Locations
  • Human Mutation (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Funders
  • National Institutes of Health (5p50hl074728-05)
  • National Heart, Lung, and Blood Institute (HL 074728, HL 71207, P50-HL074728, R01HL071207)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD01294, K24HD001294)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
Noonan syndrome, LEOPARD syndrome, cardiofaciocutaneous syndrome, RAS/MAPK pathway, phenotypic spectrum, de novo missense variant, gain-of-function, allele-specific effects, genotype-phenotype correlation, developmental disorders
MeSH terms
Abnormalities, Multiple, Face, Female, Gene Frequency, Genotype, Heart Defects, Congenital, Humans, Male, Noonan Syndrome, Phenotype, Skin Abnormalities, Genetic Variation, Cohort Studies, Germ-Line Mutation, Mutation, Missense, LEOPARD Syndrome, Proto-Oncogene Proteins B-raf

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review